Following the successful clinical launch of our intravenous therapy, our long-term vision is to leverage this versatile technology across broader clinical applications. By expanding into oral formulations and outpatient settings, we aim to bridge the gap between intensive hospital care and long-term recovery, eventually bringing our antifungal breakthrough to diverse global markets like veterinary, agriculture or food.